These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18038714)

  • 1. Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome.
    Sinha SK; Bhangoo A; Anhalt H; Maclaren N; Marshall JD; Collin GB; Naggert JK; Ten S
    J Pediatr Endocrinol Metab; 2007 Sep; 20(9):1045-52. PubMed ID: 18038714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes.
    Stafford JM; Elasy T
    Vasc Health Risk Manag; 2007; 3(4):503-10. PubMed ID: 17969380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: "Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome", Sinha SK et al., JPEM 2007; 20: 1045-1052.
    Atabek ME
    J Pediatr Endocrinol Metab; 2008 Jan; 21(1):100; author reply 100-1. PubMed ID: 18404981
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of metformin and rosiglitazone on peripheral insulin resistance and β-cell function in obesity: a double-blind, randomized, controlled study.
    Li X; Zhang N; Li Y; Shi Y; Li D; Xie Y; Xie Y; Ming J
    J Int Med Res; 2011; 39(2):358-65. PubMed ID: 21672339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.
    Smiley D; Umpierrez G
    Expert Opin Pharmacother; 2007 Jun; 8(9):1353-64. PubMed ID: 17563269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Youth-onset type 2 diabetes mellitus: lessons learned from the TODAY study.
    Narasimhan S; Weinstock RS
    Mayo Clin Proc; 2014 Jun; 89(6):806-16. PubMed ID: 24702733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance.
    Retnakaran R; Qi Y; Harris SB; Hanley AJ; Zinman B
    Diabetes Care; 2011 Jul; 34(7):1601-4. PubMed ID: 21709296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone maleate/metformin hydrochloride: a new formulation therapy for type 2 diabetes.
    Cox SL
    Drugs Today (Barc); 2004 Jul; 40(7):633-43. PubMed ID: 15510236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans: a pilot study.
    Bellot-Rojas P; Posadas-Sanchez R; Caracas-Portilla N; Zamora-Gonzalez J; Cardoso-Saldaña G; Jurado-Santacruz F; Posadas-Romero C
    J Drugs Dermatol; 2006 Oct; 5(9):884-9. PubMed ID: 17039655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
    Baillargeon JP; Jakubowicz DJ; Iuorno MJ; Jakubowicz S; Nestler JE
    Fertil Steril; 2004 Oct; 82(4):893-902. PubMed ID: 15482765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.
    Zinman B; Harris SB; Neuman J; Gerstein HC; Retnakaran RR; Raboud J; Qi Y; Hanley AJ
    Lancet; 2010 Jul; 376(9735):103-11. PubMed ID: 20605202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
    Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
    Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
    Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
    Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial.
    Silic A; Janez A; Tomazic J; Karner P; Vidmar L; Sharma P; Maticic M
    Croat Med J; 2007 Dec; 48(6):791-9. PubMed ID: 18074413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
    Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy].
    Orbetsova M; Kamenov Z; Kolarov G; Zakharieva S; Khristov V; Atanasova I; Shigarminova R; Milcheva B; Genchev G
    Akush Ginekol (Sofiia); 2006; 45(7):16-28. PubMed ID: 17489164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.
    Kahn SE; Lachin JM; Zinman B; Haffner SM; Aftring RP; Paul G; Kravitz BG; Herman WH; Viberti G; Holman RR;
    Diabetes; 2011 May; 60(5):1552-60. PubMed ID: 21415383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.